Abstract

Low-passage, serum-free cell lines cultured from patient tumour tissue are the gold-standard for preclinical studies and cellular investigations of glioblastoma (GBM) biology, yet entrenched, poorly-representative cell line models are still widely used, compromising the significance of much GBM research. We submit that greater adoption of these critical resources will be promoted by the provision of a suitably-sized, meaningfully-described reference collection along with appropriate tools for working with them. Consequently, we present a curated panel of 12 readily-usable, genetically-diverse, tumourigenic, patient-derived, low-passage, serum-free cell lines representing the spectrum of molecular subtypes of IDH-wildtype GBM along with their detailed phenotypic characterisation plus a bespoke set of lentiviral plasmids for bioluminescent/fluorescent labelling, gene expression and CRISPR/Cas9-mediated gene inactivation. The cell lines and all accompanying data are readily-accessible via a single website, Q-Cell (qimrberghofer.edu.au/q-cell/) and all plasmids are available from Addgene. These resources should prove valuable to investigators seeking readily-usable, well-characterised, clinically-relevant, gold-standard models of GBM.

Details

Title
A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma
Author
Stringer, Brett W 1   VIAFID ORCID Logo  ; Day, Bryan W 1 ; D’Souza Rochelle C J 1 ; Jamieson, Paul R 1 ; Ensbey, Kathleen S 1 ; Bruce, Zara C 1 ; Lim, Yi Chieh 1 ; Goasdoué Kate 1 ; Offenhäuser Carolin 1 ; Akgül Seçkin 1 ; Allan, Suzanne 2 ; Robertson, Thomas 3 ; Lucas, Peter 3 ; Tollesson Gert 3 ; Campbell, Scott 3 ; Winter, Craig 3 ; Do Hongdo 4 ; Dobrovic Alexander 4   VIAFID ORCID Logo  ; Po-Ling, Inglis 2 ; Jeffree, Rosalind L 5 ; Johns, Terrance G 6 ; Boyd, Andrew W 7 

 QIMR Berghofer Medical Research Institute, Brisbane, Australia (GRID:grid.1049.c) (ISNI:0000 0001 2294 1395) 
 QIMR Berghofer Medical Research Institute, Brisbane, Australia (GRID:grid.1049.c) (ISNI:0000 0001 2294 1395); Royal Brisbane and Women’s Hospital, Brisbane, Australia (GRID:grid.416100.2) (ISNI:0000 0001 0688 4634) 
 Royal Brisbane and Women’s Hospital, Brisbane, Australia (GRID:grid.416100.2) (ISNI:0000 0001 0688 4634) 
 Olivia Newton-John Cancer and Wellness Centre, Melbourne, Australia (GRID:grid.416100.2) 
 Royal Brisbane and Women’s Hospital, Brisbane, Australia (GRID:grid.416100.2) (ISNI:0000 0001 0688 4634); The University of Queensland, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537) 
 Hudson Institute of Medical Research, Clayton, Victoria, Australia (GRID:grid.452824.d) 
 QIMR Berghofer Medical Research Institute, Brisbane, Australia (GRID:grid.1049.c) (ISNI:0000 0001 2294 1395); The University of Queensland, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537) 
Publication year
2019
Publication date
Dec 2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2194570348
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.